Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
9,48 USD | +5,22 % | +5,10 % | +23,44 % |
21/05 | ASTRIA THERAPEUTICS, INC. : Oppenheimer da una recomendación de compra | ZM |
09/05 | Astria Therapeutics, Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024 | CI |
Resumen de negocios
Número de empleados: 59
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jill Milne
FOU | Founder | 56 | 26/06/08 |
Noah Clauser
DFI | Director of Finance/CFO | 51 | 01/04/11 |
Chief Tech/Sci/R&D Officer | 54 | 15/07/22 | |
John Ruesch
PRN | Corporate Officer/Principal | - | 17/07/23 |
Keri McGrail
HRO | Human Resources Officer | - | 01/03/21 |
Andrew Komjathy
PRN | Corporate Officer/Principal | 61 | 25/09/19 |
Ben Harshbarger
LAW | General Counsel | 55 | 12/06/20 |
Andrea Matthews
PRN | Corporate Officer/Principal | 42 | 01/07/14 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 01/01/14 |
Gregg Lapointe
BRD | Director/Board Member | 65 | 04/01/19 |
Director/Board Member | 75 | 05/04/16 | |
Jonathan Violin
BRD | Director/Board Member | 48 | 28/01/21 |
Jill Milne
FOU | Founder | 56 | 26/06/08 |
Hugh Cole
BRD | Director/Board Member | 59 | 26/07/19 |
Joanne Beck
BRD | Director/Board Member | 63 | 14/02/19 |
Director/Board Member | 56 | 28/01/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 54 913 061 | 48 159 943 ( 87,70 %) | 0 | 87,70 % |
Acción B | 0 | 31 107 | 0 | 0 |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+23,44 % | 520 M | |
+11,60 % | 106 mil M | |
-4,68 % | 24,28 mil M | |
-0,82 % | 21,96 mil M | |
-10,12 % | 18,16 mil M | |
-42,12 % | 16,37 mil M | |
-17,47 % | 15,56 mil M | |
+2,77 % | 13,63 mil M | |
+34,58 % | 12,27 mil M | |
+77,64 % | 8873,08 M |
- Bolsa de valores
- Acciones
- Acción ATXS
- Empresa Astria Therapeutics, Inc.